VITR: Vitrolife AB (publ) - Summary | Jitta

Vitrolife AB (publ)

SWE:VITR

Price
kr106.80
Loss Chance
49.2%
4.18JITTA SCORE
93.95%Over Jitta Line
Jitta Ranking
63 / 107
446 / 616
Grow your money with Jitta Ranking. See details.
HISTORICAL JITTA SCORE
Jitta Factors
Growth Opportunity (30)
Recent Business Performance (20)
Financial Strength (79)
Return to Shareholders (19)
Competitive Advantage (34)
Jitta Signs
Dividend PayoutIncreasing Every Year
Interest Coverage RatioVery Good
Revenue and EarningEarning decline from 2022-2025
Operating MarginDeclined
Recent Business PerformanceEarning decline 55.60% in the last year
SG&A to SalesIncreasing Every Year
Key Stats
Jitta Score
Jitta Line
4.18
93.95%
2.24
119.80%
2.89
152.39%
Biotechnology
2.77
100.00%
6.92
400.08%
4.48
371.58%
COMPANY DESCRIPTION
Vitrolife AB (publ) provides assisted reproduction products in Europe, the Middle East, Africa, Asia-Pacific, and the Americas. It offers sperm processing, oocyte retrieval needles, micromanipulation pipettes, time-lapse systems, and evaluation tools, laser and imaging systems, IVF media and oil, embryo transfer, cryopreservation, and genomics kits. The company also provides eWitness and Labware products, such as dishes, pipettes, tubes, and VitroTemp. The company was incorporated in 1989 and is based in Gothenburg, Sweden.